Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Fuji
Johnson and Johnson
Harvard Business School
AstraZeneca
Fish and Richardson
Cantor Fitzgerald
Chubb
UBS

Generated: July 16, 2018

DrugPatentWatch Database Preview

Actavis Inc Company Profile

« Back to Dashboard

What is the competitive landscape for ACTAVIS INC, and what generic and branded alternatives to ACTAVIS INC drugs are available?

ACTAVIS INC has five approved drugs.



Summary for Actavis Inc
US Patents:0
Tradenames:5
Ingredients:5
NDAs:5
Patent Litigation for Actavis Inc: See patent lawsuits for Actavis Inc

Drugs and US Patents for Actavis Inc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Actavis Inc GEMCITABINE HYDROCHLORIDE gemcitabine hydrochloride INJECTABLE;INJECTION 204549-002 Apr 11, 2016 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Actavis Inc ZOLEDRONIC ACID zoledronic acid INJECTABLE;IV (INFUSION) 202472-001 Mar 4, 2013 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Actavis Inc GEMCITABINE HYDROCHLORIDE gemcitabine hydrochloride INJECTABLE;INJECTION 204549-003 Apr 11, 2016 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Actavis Inc METHOXSALEN methoxsalen CAPSULE;ORAL 202603-001 Jun 9, 2015 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Merck
Boehringer Ingelheim
Queensland Health
UBS
Daiichi Sankyo
Dow
Healthtrust
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.